Items tagged with Treatment

Are pretomanid-containing regimens for TB a victory or a victory narrative? (post with simple image)

"Given the evidence base available to us currently, can we claim pretomanid a victory? We think more research is needed before pretomanid can be celebrated as a promising treatment for people with tuberculosis."

TB Alliance responds to questions raised by activists in relation to pretomanid (post with simple image)

MSF, TAG and TB CAB raised a number of outstanding medical and research questions regarding pretomanid and the regimen BPaL.

WHO announces changes to the treatment of drug-resistant TB (post with simple image)

WHO releases a Rapid Communication in advance of the updated guidelines for the treatment of drug-resistant TB expected in 2020.

MSF calls on Johnson & Johnson to lower price of lifesaving TB drug (post with simple image)

Group protests at New York Stock Exchange as Johnson & Johnson releases earnings report.

Stop TB Partnership and Johnson & Johnson announce price reduction for bedaquiline (post with simple image)

Stop TB Partnership and Johnson & Johnson, with support from USAID and the Global Fund, announce price reduction for bedaquiline for treatment of drug-resistant TB in low- and middle-income countries.

Johnson & Johnson TB drug price reduction is important step, and governments need to urgently scale up better treatment (post with simple image)

120,707 people signed petitions urging the corporation to drop the price.

Treatment Action Group statement on bedaquiline unaffordability (post with simple image)

Bedaquiline is a public good, and must be treated as such. Johnson & Johnson once again refused to meet evidence-based demands to price bedaquiline at $1/day.

TB CAB Statement (post with simple image)

TB CAB Access Considerations Statement Regarding Johnson & Johnson Announcement of Bedaquiline Price Reduction

Page 80 of 80 · Total posts: 0

←First 79 80